UnitedHealth Group (UNH) is Great Lakes Advisors LLC’s 4th Largest Position

Great Lakes Advisors LLC decreased its holdings in UnitedHealth Group (NYSE:UNH) by 1.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 384,907 shares of the healthcare conglomerate’s stock after selling 7,286 shares during the period. UnitedHealth Group accounts for approximately 1.8% of Great Lakes Advisors LLC’s holdings, making the stock its 4th biggest holding. Great Lakes Advisors LLC’s holdings in UnitedHealth Group were worth $75,068,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of UNH. MUFG Securities EMEA plc raised its position in UnitedHealth Group by 67.6% in the 3rd quarter. MUFG Securities EMEA plc now owns 285,000 shares of the healthcare conglomerate’s stock worth $55,817,000 after purchasing an additional 115,000 shares during the period. Capital Planning Advisors LLC increased its position in shares of UnitedHealth Group by 89.7% during the third quarter. Capital Planning Advisors LLC now owns 7,310 shares of the healthcare conglomerate’s stock worth $1,432,000 after acquiring an additional 3,456 shares during the period. Oppenheimer & Co. Inc. increased its position in shares of UnitedHealth Group by 49.7% during the third quarter. Oppenheimer & Co. Inc. now owns 32,784 shares of the healthcare conglomerate’s stock worth $6,420,000 after acquiring an additional 10,889 shares during the period. Robecosam AG increased its position in shares of UnitedHealth Group by 10.3% during the third quarter. Robecosam AG now owns 86,977 shares of the healthcare conglomerate’s stock worth $17,056,000 after acquiring an additional 8,152 shares during the period. Finally, NorthCoast Asset Management LLC increased its position in shares of UnitedHealth Group by 14.1% during the third quarter. NorthCoast Asset Management LLC now owns 4,309 shares of the healthcare conglomerate’s stock worth $844,000 after acquiring an additional 532 shares during the period. 85.10% of the stock is currently owned by institutional investors.

A number of equities analysts have recently commented on the stock. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 28th. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group to $266.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 18th. Finally, Oppenheimer raised their target price on shares of UnitedHealth Group from $260.00 to $276.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 18th. One research analyst has rated the stock with a hold rating and twenty-seven have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $254.66.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 14,233 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total value of $3,276,721.26. Following the completion of the sale, the chief executive officer now directly owns 18,219 shares in the company, valued at $4,194,378.18. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 10,400 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $229.87, for a total transaction of $2,390,648.00. Following the completion of the sale, the director now owns 1,781,657 shares of the company’s stock, valued at $409,549,494.59. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 87,019 shares of company stock valued at $20,283,033. 0.87% of the stock is owned by insiders.

Shares of UnitedHealth Group opened at $244.26 on Thursday, Marketbeat Ratings reports. The company has a market cap of $238.23 billion, a P/E ratio of 24.26, a price-to-earnings-growth ratio of 1.43 and a beta of 0.75. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.71 and a current ratio of 0.71. UnitedHealth Group has a 52-week low of $174.52 and a 52-week high of $250.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.91 by $0.13. The company had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. UnitedHealth Group’s revenue was up 13.3% compared to the same quarter last year. During the same period last year, the company posted $2.37 earnings per share. sell-side analysts anticipate that UnitedHealth Group will post 12.61 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply